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节特性相关并且 Rap1蛋白是 NF-κ B信号通路中的重要调控蛋白,因此 Rap1基因

















帕霉素（1X Rapa），2X 雷帕霉素（2X Rapa），1X 雷帕霉素联合 RWT-MSCs，2X
雷帕霉素联合 RWT-MSCs，1X雷帕霉素联合 RKO-MSCs，2X雷帕霉素联合 RKO-MSCs




















小鼠移植排斥时血清蛋白因子浓度进行检测，发现 2X 雷帕霉素联合 RWT-MSCs
























Background Mesenchymal stem cells have the great application prospect in the 
field of transplantation immunity with their property of low immunogenicity and 
immunosuppression. There is close relationship between the immunoregulationability 
of MSCs and NF-κB signaling pathway. Recent studies have identified Rap1 as an 
essential modulator of NF-κB-mediated pathways. NF-κB is induced by ectopic 
expression of Rap1, whereas its activity is inhibited by Rap1 depletion. Through 
comparing the immunoregulation between RKO-MSCs and RWT-MSCs, we intend to 
study the roles of NF-κB signaling pathway in MSC-mediated immune rejection 
response. 
Materials and Results First, bone marrow mesenchymal stem cells from Rap1 
knockout mice (RKO-MSCs) and their homologous wild type mice (RWT-MSCs) 
were isolated and well characterized. Then we compared the differences of 
immunoregulation ability between RKO-MSCs and RWT-MSCs by using in vitro 
mixed lymphocyte reaction (MLR).RKO-MSCs and RWT-MSCs demonstrated 
equivalent ability to inhibit proliferation of MLR (p>0.05). However, culture 
supernatants of RWT-MSCs had better effect in suppressing MLR proliferation than 
RKO-MSCs (p<0.01). This phenomenon could be partially explained by the 
differences of soluble factor between RKO-MSCs and RWT-MSCs as flow cytomix 
showed that RWT-MSCs secreted more pro-inflammatory cytokines and 
anti-inflammatory cytokines than RKO-MSCs(p<0.05).In mouse heart transplantation 
model, rapamycin (Rapa) in low/high dosage was combined with MSCs, grouped as 
following: 1) 1x Rapa (low Rapa); 2) 2x Rapa (high Rapa); 3) 1x Rapa + RWT-MSCs; 
4) 2x Rapa + RWT-MSCs; 5) 1x Rapa + RKO-MSCs; 6) 2x Rapa + RKO-MSCs.2x 
Rapa + RWT-MSCs(group4) can obviously prolong the cardiac allograft survival than 
other groups (p<0.01)The worst group was RWT-MSCs combined with low dose of 
















the longest allograft survival up to 30 days was appeared in RWT-MSCs combined 
with high dose of Rapa (group 4), with less inflammatory cells infiltration and 
increased expression of Foxp3, detected by HE and immunefluorescence 
staining(P<0.01), respectively. Correspondingly, the lowest serum protein level of 
pro-inflammatory factors, including IFN-γ, IL–10, TNF-α and IL–6 was detected in 
RWT-MSCs combined high dose of Rapa group (group 4). (p<0.001)Aiming at 
emphasizing paracrine differences between RKO-MSCs and RWT-MSCs in 
immonoregulation, we used biological material to capsulize MSCs for heart 
transplantation modeling, and achieved similar tendency of survival curve. 2x Rapa + 
Encapsulated RWT-MSCs can obviously prolong the cardiac allograft survival than 
other groups (p<0.05). 
Conclusions RWT-MSCs processed more stable and reliable immune-suppressing 
capability than RKO-MSCs by secreting cytokines to inhibit inflammatory. 
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